AWARD-2 : Trulicity® vs insuline glargine,
en association à la metformine et à un sulfamide hypoglycémiant sur 78 semaines 1
chez des patients diabétiques de type 2
AWARD: Assessment of Weekly AdministRation of dulaglutide in Diabetes
1. Giorgino F, et al. Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2). Diabetes Care. 2015;38(12):2241-9.